Jefferies reiterated a Buy rating and $16.50 price target on Allscripts (NASDAQ: MDRX) following 4Q earnings report. MDRX reported EPS ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

Allscripts (MDRX) PT Raised to $13 at Cantor Fitzgerald Following In-Line 4Q ResultsFebruary 17, 2017 7:22 AM Allscripts (MDRX) Misses Q4 EPS by 1c, Offers GuidnceFebruary 16, 2017 4:05 PM Allscripts announces fourth quarter and 2016 full-year resultsFebruary 16, 2017 4:01 PM